Abstract :
Trials indicate that screening women between 40 and 49 with mammography results in a clear mortality benefit. Whether this is worth the side-effects and financial cost is a matter of judgement. Some national health authorities and several other bodies consider the balance favourable enough to recommend general screening for this age group.
